FMW Media's New to the Street, a nationally televised business show, and The Sustainable Green Team, Ltd. (OTC: SGTM) ($SGTM) ("Company") announces a 6-year media agreement
Read MoreCompany's Canalevia®-CA1 prescription drug is FDA conditionally approved for treatment of chemotherapy-induced diarrhea (CID) in dogs and is the first and only treatment for CID in dogs to receive any type of approval from FDA
Read MoreModerna's updated COVID-19 mRNA vaccine will be available for the 2024-2025 vaccination season, pending a European Commission authorization decision
Read MoreDomitner GmbH placed initial order that is expected to ship in the third quarter of 2024
Combined with the German distribution announced in July, there is strong coverage in central Europe
Additional European distributors are expected to be secured in 2024
MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetes
Designed to be simpler and more affordable to expand access to diabetes technology for previously underserved communities
Commercial availability expected in early 2025
Click here to view interview video
Paramount near-term activities include planned October 2024 commercial launch of FDA-approved oral mucositis prescription product Gelclair® and results from independent, investigator-initiated trials of crofelemer for rare diseases
Read More
